Votes & Verdicts

• Netflix/Paramount Antitrust, AI EO, Farm Aid

  Analysis by Jen Rie of antitrust risk related to Netflix and Paramount Skydance bids for Warner Bros. Discovery led Bloomberg Intelligence’s Votes and Verdicts podcast this week. Justin Teresi analyzed Supreme Court arguments over US President Donald Trump’s ability to fire FTC commissioners and what it means for cases against pharmacy benefit managers and others, while Elliott Stein discussed the implications for the Federal Reserve Board. Matt Schettenhelm explored if the president’s anticipated artificial intelligence executive order can block state AI regulations. Nathan Dean discussed Trump’s proposed $12 billion farm-aid package and what it means for companies like Corteva and Nutrien. And Holly Froum discussed anticipated timing for the Supreme Court’s tariffs opinion and the outlook for lawsuits concerning tariff refunds.See omnystudio.com/listener for privacy information.

  --------  

  43:48

  --------

  43:48
• Warner Bros. Bids, Zillow, Bayer in SCOTUS

  Analysis of antitrust risk attendant to bids for Warner Bros. Discovery by Comcast, Netflix and Paramount Skydance was among the topics discussed on Bloomberg Intelligence’s Votes and Verdicts podcast this week. Jen Rie explored that issue, while Justin Teresi analyzed Real Page’s settlement with the Justice Department over alleged collusion in the real estate rental market as well as Compass’ antitrust suit against Zillow for allegedly steering consumers to real estate agents who pay for placement. Matt Schettenhelm addressed the potential for owners of US TV stations, like Nexstar, to consolidate if the FCC eases existing ownership rules. Nathan Dean discussed deregulation for regional banks like US Bancorp and PNC. Holly Froum analyzed Bayer’s petition for Supreme Court review in Roundup weedkiller litigation.See omnystudio.com/listener for privacy information.

  --------  

  43:48

  --------

  43:48
• Meta Win, Trump’s AI Order, Epstein/JPMorgan

  Key takeaways from Meta’s trial-court win over the FTC’s antitrust suit leads Bloomberg Intelligence’s Votes and Verdicts podcast this week. Jen Rie discusses that case, while BI litigation and policy analysts examine other critical issues, including potential preemption of state laws concerning artificial intelligence and President Donald Trump’s anticipated executive order on the subject. Nathan Dean discusses potential effects on companies like Apple, Skechers and Steve Madden of proposed bipartisan legislation to impose tariffs on countries that buy Russian oil. Elliott Stein analyzes the strength of the Justice Department’s investigation of JPMorgan and its ties to Jeffrey Epstein, and Holly Froum provides an update on an appeals court hearing that might revive claims alleging Tylenol causes autism and ADHD.See omnystudio.com/listener for privacy information.

  --------  

  39:03

  --------

  39:03
• ACA Future, CFPB Funds, Visa/Mastercard Pact

  Key takeaways from the end of the US government shutdown led this week’s episode of Bloomberg Intelligence’s Votes and Verdicts podcast. Nathan Dean and Duane Wright discussed the terms of the agreement and what they mean for the future of Affordable Care Act subsidies and companies like Centene and UnitedHealth. BI’s litigation and policy analysts also discussed other key developments, including the Consumer Financial Protection Bureau’s Nov. 11 notice that it can’t draw funds from the Federal Reserve while the central bank operates at a loss. Justin Teresi reviewed a Nov. 10 proposed class settlement between Visa, Mastercard and merchants involving about $38 billion in interchange-fee concessions and related policy changes.See omnystudio.com/listener for privacy information.

  --------  

  27:19

  --------

  27:19
• Tariffs in SCOTUS; Pfizer v. Novo, Metsera

  Key takeaways from Supreme Court arguments on Nov. 5 over the legality of the Trump administration's reciprocal and fentanyl-linked tariffs led Bloomberg Intelligence's Votes and Verdicts podcast this week. Holly Froum examined that while BI litigation and policy analysts discuss other important catalysts. Holly and Jen Rie analyzed litigation concerning a bidding war between Pfizer and Novo Nordisk for Metsera, a clinical-stage biotech company that makes anti-obesity drugs. Holly and Jen also discussed legal issues pertaining to Kimberly-Clark's $48 billion acquisition of Kenvue. Nathan Dean offered his views on paths being discussed to end the government shutdown.See omnystudio.com/listener for privacy information.

  --------  

  42:50

  --------

  42:50

More Business podcasts

Trending Business podcasts

About Votes & Verdicts

Votes & Verdicts: Podcasts in Family